PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Growth in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a large growth in short interest in January. As of January 30th, there was short interest totaling 56,594 shares, a growth of 69.4% from the January 15th total of 33,408 shares. Based on an average daily volume of 144,900 shares, the short-interest ratio is currently 0.4 days. Based on an average daily volume of 144,900 shares, the short-interest ratio is currently 0.4 days.

PureTech Health Stock Down 0.0%

Shares of OTCMKTS:PTCHF opened at $1.70 on Monday. PureTech Health has a 12-month low of $1.27 and a 12-month high of $1.90. The business’s 50 day moving average is $1.72 and its 200 day moving average is $1.70.

About PureTech Health

PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.

The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.